CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +8,643 | $2.90 | $25K | 316,615 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −8,643 | $45.43 | $393K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +4,817 | $2.90 | $14K | 312,789 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −4,817 | $46.62 | $225K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +2,165 | $2.90 | $6K | 310,137 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −2,165 | $47.06 | $102K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +975 | $2.90 | $3K | 308,947 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −975 | $45.48 | $44K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +900 | $2.90 | $3K | 308,872 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −900 | $46.79 | $42K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +975 | $2.90 | $3K | 308,947 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −975 | $45.43 | $44K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +900 | $2.90 | $3K | 308,872 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −900 | $46.79 | $42K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +975 | $2.90 | $3K | 308,947 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −975 | $45.48 | $44K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +900 | $2.90 | $3K | 308,872 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −900 | $46.79 | $42K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +975 | $2.90 | $3K | 308,947 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −975 | $45.44 | $44K | 307,972 |
Page 11 of 17 · 321 trades